Immediate Impact

39 by Nobel laureates 13 from Science/Nature 67 standout
Sub-graph 1 of 21

Citing Papers

HIFs, angiogenesis, and metabolism: elusive enemies in breast cancer
2020 Standout
A view on drug resistance in cancer
2019 StandoutNature
5 intermediate papers

Works of Kenneth A. Kern being referenced

First-Line Treatment of Advanced Breast Cancer With Sunitinib in Combination With Docetaxel Versus Docetaxel Alone: Results of a Prospective, Randomized Phase III Study
2012
Phase III randomized trial of sunitinib versus capecitabine in patients with previously treated HER2-negative advanced breast cancer
2010
and 1 more

Author Peers

Author Last Decade Papers Cites
Kenneth A. Kern 971 653 713 732 71 2.6k
Emmanuel E. Zervos 1854 580 1463 843 128 3.6k
Steven Gallinger 2174 680 1005 769 89 4.2k
Mary A. Maluccio 1103 670 1181 655 76 4.3k
M K Palmer 1986 1030 735 560 51 3.9k
Kenji Takenaka 1182 694 1627 667 138 4.2k
Jyrki Mäkelä 2441 808 2352 363 129 4.4k
Norma Alkjærsig 462 1589 514 1244 86 4.9k
Alex McMillan 925 703 576 708 55 3.4k
P Selby 1009 294 320 264 57 2.5k
Stefan Mönig 849 1863 1725 329 143 3.4k

All Works

Loading papers...

Rankless by CCL
2026